Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-15
2005-02-15
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S234500, C514S253090, C514S254060, C514S394000, C544S139000, C544S364000, C544S370000, C544S359000, C546S273400, C548S310100, C548S310700, C548S309700, C548S304700, C548S306100
Reexamination Certificate
active
06855714
ABSTRACT:
The invention relates to novel benzimidazole derivatives with general formula I, whereby radicals R1, R2, R3, A, B and Y have the meanings that are indicated in the description and the claims, the use of these compounds for the production of a pharmaceutical agent for treating and for preventing diseases that are associated with microglia activation, as well as pharmaceutical preparations that contain these compounds.
REFERENCES:
patent: 5552426 (1996-09-01), Lunn et al.
patent: 20020006948 (2002-01-01), Halfbrodt et al.
patent: WO 9507263 (1995-03-01), None
patent: WO 0151473 (2001-07-01), None
Blume Thorsten
Elger Bernd
Halfbrodt Wolfgang
Kuhnke Joachim
Moenning Ursula
Hermenau Ronald S.
Schering Aktiengesellschaft
Stockton Laura L.
Washtien Wendy L.
LandOfFree
1-alkyl-2-aryl-benzimidazole derivatives, their use for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-alkyl-2-aryl-benzimidazole derivatives, their use for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-alkyl-2-aryl-benzimidazole derivatives, their use for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3473249